Lin Z - Search Results

1

miR-6089/MYH9/β-catenin/c-Jun negative feedback loop inhibits ovarian cancer carcinogenesis and progression.

Liu L, Ning Y, Yi J, Yuan J, Fang W, Lin Z, Zeng Z. Liu L, et al. Among authors: lin z. Biomed Pharmacother. 2020 May;125:109865. doi: 10.1016/j.biopha.2020.109865. Epub 2020 Feb 12. Biomed Pharmacother. 2020. PMID: 32058212 Free article.

2

Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in cervical cancer.

Yao T, Rao Q, Liu L, Zheng C, Xie Q, Liang J, Lin Z. Yao T, et al. Among authors: lin z. Virol J. 2013 Jun 3;10:175. doi: 10.1186/1743-422X-10-175. Virol J. 2013. PMID: 23732000 Free PMC article.

3

Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21.

Zhang J, Yao T, Wang Y, Yu J, Liu Y, Lin Z. Zhang J, et al. Among authors: lin z. Cancer Biol Ther. 2016;17(1):104-13. doi: 10.1080/15384047.2015.1108496. Cancer Biol Ther. 2016. PMID: 26574780 Free PMC article.

4

Growth arrest-specific 5 attenuates cisplatin-induced apoptosis in cervical cancer by regulating STAT3 signaling via miR-21.

Yao T, Lu R, Zhang J, Fang X, Fan L, Huang C, Lin R, Lin Z. Yao T, et al. Among authors: lin r, lin z. J Cell Physiol. 2019 Jun;234(6):9605-9615. doi: 10.1002/jcp.27647. Epub 2018 Oct 23. J Cell Physiol. 2019. PMID: 30352127

5

Expression and clinical significance of transcription factor 4 (TCF4) in epithelial ovarian cancer.

Liu L, Zeng Z, Yi J, Zuo L, Lv J, Yuan J, Lin Z, Luo R, Feng X. Liu L, et al. Among authors: lin z. Cancer Biomark. 2019;24(2):213-221. doi: 10.3233/CBM-181849. Cancer Biomark. 2019. PMID: 30614797

6

MYH9 overexpression correlates with clinicopathological parameters and poor prognosis of epithelial ovarian cancer.

Liu L, Yi J, Deng X, Yuan J, Zhou B, Lin Z, Zeng Z. Liu L, et al. Among authors: lin z. Oncol Lett. 2019 Aug;18(2):1049-1056. doi: 10.3892/ol.2019.10406. Epub 2019 May 27. Oncol Lett. 2019. PMID: 31423165 Free PMC article.

7

Low expression of KIF7 indicates poor prognosis in epithelial ovarian cancer.

Yao Y, Liu L, He W, Lin X, Zhang X, Lin Z, Zeng Z, Guo S. Yao Y, et al. Among authors: lin z, lin x. Cancer Biomark. 2019;26(4):481-489. doi: 10.3233/CBM-190328. Cancer Biomark. 2019. PMID: 31658044

8

LGR4 overexpression is associated with clinical parameters and poor prognosis of serous ovarian cancer.

Zeng Z, Ji N, Yi J, Lv J, Yuan J, Lin Z, Liu L, Feng X. Zeng Z, et al. Among authors: lin z. Cancer Biomark. 2020;28(1):65-72. doi: 10.3233/CBM-191145. Cancer Biomark. 2020. PMID: 32176632

9

FOXO1 overexpression is correlated with poor prognosis in epithelial ovarian cancer.

Liu L, Yi J, Yuan J, Yao T, Lin Z, Ning Y, Zeng Z. Liu L, et al. Among authors: lin z. Cancer Biomark. 2020;28(1):1-8. doi: 10.3233/CBM-182119. Cancer Biomark. 2020. PMID: 32224523

10

Expression and Clinical Significance of Microtubule-Actin Cross-Linking Factor 1 in Serous Ovarian Cancer.

Liu L, Hu K, Zeng Z, Xu C, Lv J, Lin Z, Wen B. Liu L, et al. Among authors: lin z. Recent Pat Anticancer Drug Discov. 2021;16(1):66-72. doi: 10.2174/1574892816666210211091543. Recent Pat Anticancer Drug Discov. 2021. PMID: 33573562

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19,741 results

Search Page

Filters